Drug Supply Chain Feels the Trump Effect
A small gesture on pricing is prone to have a huge impact on the prescription drug trade.
On Tuesday night, Pfizersaid it could defer deliberate worth will increase on about 10% of its prescription medicines after President Donald Trump spoke with CEO Ian Learn and criticized the corporate on Twitter. Pfizer had deliberate to lift the checklist costs of some medicine by as a lot as 9.four%, a part of the annual worth will increase it and different drug firms impose yearly on July 1. Record costs are sticker costs, earlier than rebates and reductions…
Supply hyperlink – https://www.wsj.com/articles/drug-supply-chain-feels-the-trump-effect-1531301404?mod=pls_whats_news_us_business_f